CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

Conditions: B-Cell Leukemia; Non-Hodgkin ' s Lymphoma; B-cell Acute Lymphoblastic Leukemia; Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma; Primary Mediastinal Large B-cell Lymphoma (PMBCL); Mantle Cell Lymphoma; B-cell Lymphoma Interventions: Biological: CLIC-2201 Sponsors: British Columbia Cancer Agency Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials